Kuoyuan Cheng

1.9k total citations
16 papers, 267 citations indexed

About

Kuoyuan Cheng is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Kuoyuan Cheng has authored 16 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Kuoyuan Cheng's work include SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Kuoyuan Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Kuoyuan Cheng collaborates with scholars based in United States, Israel and China. Kuoyuan Cheng's co-authors include Eytan Ruppin, Sanju Sinha, Alejandro A. Schäffer, Eyal Schiff, Kenneth Aldape, Nishanth Ulhas Nair, Qing Xia, Xudong Feng, Joo Sang Lee and Fei Guo and has published in prestigious journals such as Nature Communications, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Kuoyuan Cheng

15 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kuoyuan Cheng United States	9	146	66	25	24	22	16	267
Marie Ståhlberg Sweden	6	147 1.0×	101 1.5×	18 0.7×	17 0.7×	15 0.7×	7	340
Mir S. Adil United States	9	154 1.1×	60 0.9×	28 1.1×	37 1.5×	21 1.0×	25	372
Chia-Hua Wu Taiwan	8	145 1.0×	31 0.5×	35 1.4×	15 0.6×	32 1.5×	18	369
Yang Xue China	11	102 0.7×	63 1.0×	26 1.0×	25 1.0×	17 0.8×	21	265
Richard Van Krieken Canada	9	106 0.7×	88 1.3×	58 2.3×	13 0.5×	15 0.7×	10	296
Éssia de Almeida Lima Brazil	8	83 0.6×	93 1.4×	24 1.0×	17 0.7×	20 0.9×	14	238
Kumar Parijat Tripathi Italy	10	188 1.3×	24 0.4×	18 0.7×	33 1.4×	16 0.7×	20	420
Lien Van Eyck Belgium	8	104 0.7×	77 1.2×	23 0.9×	44 1.8×	13 0.6×	12	331
Rita Babeluk Austria	9	97 0.7×	30 0.5×	16 0.6×	14 0.6×	54 2.5×	14	309
Özlem Altay Sweden	10	195 1.3×	82 1.2×	62 2.5×	27 1.1×	65 3.0×	24	382

Countries citing papers authored by Kuoyuan Cheng

Since Specialization

Citations

This map shows the geographic impact of Kuoyuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuoyuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuoyuan Cheng more than expected).

Fields of papers citing papers by Kuoyuan Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuoyuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuoyuan Cheng. The network helps show where Kuoyuan Cheng may publish in the future.

Co-authorship network of co-authors of Kuoyuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Kuoyuan Cheng. A scholar is included among the top collaborators of Kuoyuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuoyuan Cheng. Kuoyuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nair, Nishanth Ulhas, Alejandro A. Schäffer, E. Michael Gertz, et al.. (2024). Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma. Cancer Research. 84(20). 3464–3477. 8 indexed citations

Nair, Nishanth Ulhas, Kuoyuan Cheng, Lipika R. Pal, et al.. (2022). Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk. Science Advances. 8(31). eabj7176–eabj7176. 9 indexed citations

Pal, Lipika R., Kuoyuan Cheng, Nishanth Ulhas Nair, et al.. (2022). Synthetic lethality-based prediction of anti-SARS-CoV-2 targets. iScience. 25(5). 104311–104311. 5 indexed citations

Sinha, Sanju, Kuoyuan Cheng, Sanna Madan, et al.. (2021). Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias. JCO Precision Oncology. 5(5). 1147–1150. 3 indexed citations

Israel, Ariel, Alejandro A. Schäffer, Kuoyuan Cheng, et al.. (2021). Identification of drugs associated with reduced severity of COVID-19 – a case-control study in a large population. eLife. 10. 36 indexed citations

Cheng, Kuoyuan, Laura Martin‐Sancho, Lipika R. Pal, et al.. (2021). Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets. Molecular Systems Biology. 17(11). e10260–e10260. 29 indexed citations

Sinha, Sanju, Karina Barbosa, Kuoyuan Cheng, et al.. (2021). A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing. Nature Communications. 12(1). 6512–6512. 34 indexed citations

Sukumar, Madhusudhanan, Kuoyuan Cheng, Arunakumar Gangaplara, et al.. (2021). Abstract 1527: Integrated computational and experimental analysis identifies the mitochondrial uncoupling protein 2 (Ucp2) as a key regulator of T cell anti-tumor function. Cancer Research. 81(13_Supplement). 1527–1527. 1 indexed citations

Sinha, Sanju, Kuoyuan Cheng, Alejandro A. Schäffer, et al.. (2021). Abstract 29: The recently approved high-TMB criteria may introduce a sex bias in response to PD1 inhibitors. Cancer Research. 81(13_Supplement). 29–29.

10.

Cheng, Kuoyuan, Nishanth Ulhas Nair, Joo Sang Lee, & Eytan Ruppin. (2021). Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity. Science Advances. 7(1). 12 indexed citations

11.

Sinha, Sanju, Kuoyuan Cheng, Alejandro A. Schäffer, et al.. (2020). In vitro and in vivo identification of clinically approved drugs that modify ACE 2 expression. Molecular Systems Biology. 16(7). e9628–e9628. 43 indexed citations

12.

Israel, Ariel, Alejandro A. Schäffer, Ilan Feldhamer, et al.. (2020). Large population study identifies drugs associated with reduced COVID-19 severity. 11 indexed citations

13.

Hodzic, Ermin, et al.. (2019). Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks. GigaScience. 8(4). 8 indexed citations

14.

Lü, Jiaqi, Kuoyuan Cheng, Bo Zhang, et al.. (2015). Novel mechanisms for superoxide-scavenging activity of human manganese superoxide dismutase determined by the K68 key acetylation site. Free Radical Biology and Medicine. 85. 114–126. 41 indexed citations

15.

Lu, Jiaqi, Kuoyuan Cheng, Bo Xu, et al.. (2015). Berberine regulates neurite outgrowth through AMPK-dependent pathways by lowering energy status. Experimental Cell Research. 334(2). 194–206. 19 indexed citations

16.

Cheng, Kuoyuan, et al.. (2014). MnTM‐4‐PyP Modulates Endogenous Antioxidant Responses and Protects Primary Cortical Neurons against Oxidative Stress. CNS Neuroscience & Therapeutics. 21(5). 435–445. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact